GeneDx Stock Based Compensation vs Depreciation Analysis

WGS Stock

57.79 0.40 0.69%

GeneDx Holdings financial indicator trend analysis is much more than just examining GeneDx Holdings Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GeneDx Holdings Corp is a good investment. Please check the relationship between GeneDx Holdings Stock Based Compensation and its Depreciation accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Stock Based Compensation vs Depreciation

Stock Based Compensation vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GeneDx Holdings Corp Stock Based Compensation account and Depreciation. At this time, the significance of the direction appears to have almost no relationship.

The correlation between GeneDx Holdings' Stock Based Compensation and Depreciation is 0.19. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Depreciation in the same time period over historical financial statements of GeneDx Holdings Corp, assuming nothing else is changed. The correlation between historical values of GeneDx Holdings' Stock Based Compensation and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of GeneDx Holdings Corp are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Stock Based Compensation i.e., GeneDx Holdings' Stock Based Compensation and Depreciation go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Depreciation

Depreciation indicates how much of GeneDx Holdings Corp value has been used up. For tax purposes GeneDx Holdings can deduct the cost of the tangible assets it purchases as business expenses. However, GeneDx Holdings Corp must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Most indicators from GeneDx Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GeneDx Holdings Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, GeneDx Holdings' Selling General Administrative is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 91.3 M in 2024, whereas Tax Provision is likely to drop (972.3 K) in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	23.4M	63.0M	35.8M	31.4M
Interest Income	79K	2.5M	2.9M	3.1M

Depreciation And Amortization Interest Income

GeneDx Holdings fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Deferred Long Term Liab	Total Current Assets	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Non Current Liabilities Total
Other Current Liab		0.97	0.46	0.7	-0.86	0.64	0.16	0.96	0.34	0.17	0.8	0.89	0.53	0.89	0.86	0.5	0.86	0.72	-0.88	-0.13	0.39	0.76	-0.68	0.14	0.42	-0.89
Total Current Liabilities	0.97		0.42	0.67	-0.75	0.75	0.23	0.9	0.2	0.28	0.63	0.78	0.58	0.75	0.82	0.31	0.82	0.8	-0.8	-0.24	0.46	0.63	-0.73	-0.03	0.47	-0.86
Other Liab	0.46	0.42		-0.09	-0.26	0.33	0.7	0.47	-0.2	0.58	0.35	0.64	0.3	0.42	0.21	-0.01	0.2	0.07	-0.17	-0.17	0.25	0.03	0.02	0.06	0.25	-0.2
Net Tangible Assets	0.7	0.67	-0.09		-0.81	0.34	-0.45	0.57	0.62	0.06	0.68	0.6	0.71	0.69	0.95	0.54	0.95	0.42	-0.92	-0.26	0.59	0.67	-0.31	0.38	0.64	-0.94
Retained Earnings	-0.86	-0.75	-0.26	-0.81		-0.2	0.29	-0.88	-0.76	0.15	-0.94	-0.81	-0.39	-0.94	-0.88	-0.82	-0.87	-0.55	0.97	-0.17	-0.2	-0.92	0.44	-0.6	-0.27	0.88
Accounts Payable	0.64	0.75	0.33	0.34	-0.2		0.61	0.46	-0.44	0.6	0.16	0.51	0.6	0.34	0.48	-0.22	0.51	0.48	-0.33	-0.68	0.63	0.11	-0.61	-0.64	0.6	-0.53
Other Assets	0.16	0.23	0.7	-0.45	0.29	0.61		0.12	-0.8	0.65	-0.18	0.24	0.11	-0.04	-0.19	-0.51	-0.17	0.03	0.3	-0.41	0.19	-0.37	-0.17	-0.66	0.14	0.16
Net Receivables	0.96	0.9	0.47	0.57	-0.88	0.46	0.12		0.43	-0.04	0.83	0.84	0.28	0.9	0.74	0.62	0.74	0.75	-0.83	0.15	0.11	0.84	-0.71	0.26	0.15	-0.77
Common Stock Shares Outstanding	0.34	0.2	-0.2	0.62	-0.76	-0.44	-0.8	0.43		-0.58	0.67	0.29	0.01	0.56	0.52	0.84	0.5	0.26	-0.69	0.53	-0.16	0.75	-0.06	0.89	-0.09	-0.5
Inventory	0.17	0.28	0.58	0.06	0.15	0.6	0.65	-0.04	-0.58		-0.15	0.28	0.74	-0.04	0.22	-0.58	0.21	-0.14	0.03	-0.87	0.81	-0.47	0.22	-0.41	0.77	-0.19
Other Current Assets	0.8	0.63	0.35	0.68	-0.94	0.16	-0.18	0.83	0.67	-0.15		0.89	0.3	0.98	0.79	0.88	0.8	0.33	-0.88	0.17	0.14	0.89	-0.35	0.58	0.23	-0.78
Deferred Long Term Liab	0.89	0.78	0.64	0.6	-0.81	0.51	0.24	0.84	0.29	0.28	0.89		0.54	0.94	0.8	0.57	0.82	0.34	-0.79	-0.19	0.42	0.67	-0.37	0.26	0.48	-0.8
Total Current Assets	0.53	0.58	0.3	0.71	-0.39	0.6	0.11	0.28	0.01	0.74	0.3	0.54		0.38	0.76	-0.08	0.75	0.14	-0.56	-0.8	0.98	0.07	0.01	-0.03	0.98	-0.74
Property Plant Equipment	0.89	0.75	0.42	0.69	-0.94	0.34	-0.04	0.9	0.56	-0.04	0.98	0.94	0.38		0.83	0.79	0.84	0.43	-0.9	0.07	0.23	0.88	-0.46	0.45	0.3	-0.84
Total Assets	0.86	0.82	0.21	0.95	-0.88	0.48	-0.19	0.74	0.52	0.22	0.79	0.8	0.76	0.83		0.53	1.0	0.49	-0.96	-0.3	0.63	0.7	-0.38	0.34	0.68	-1.0
Short Long Term Debt Total	0.5	0.31	-0.01	0.54	-0.82	-0.22	-0.51	0.62	0.84	-0.58	0.88	0.57	-0.08	0.79	0.53		0.55	0.22	-0.71	0.53	-0.24	0.91	-0.27	0.73	-0.14	-0.53
Total Stockholder Equity	0.86	0.82	0.2	0.95	-0.87	0.51	-0.17	0.74	0.5	0.21	0.8	0.82	0.75	0.84	1.0	0.55		0.47	-0.96	-0.32	0.63	0.71	-0.4	0.3	0.68	-1.0
Property Plant And Equipment Net	0.72	0.8	0.07	0.42	-0.55	0.48	0.03	0.75	0.26	-0.14	0.33	0.34	0.14	0.43	0.49	0.22	0.47		-0.57	0.16	0.01	0.57	-0.87	-0.07	-0.01	-0.55
Current Deferred Revenue	-0.88	-0.8	-0.17	-0.92	0.97	-0.33	0.3	-0.83	-0.69	0.03	-0.88	-0.79	-0.56	-0.9	-0.96	-0.71	-0.96	-0.57		0.03	-0.39	-0.86	0.46	-0.48	-0.46	0.96
Net Debt	-0.13	-0.24	-0.17	-0.26	-0.17	-0.68	-0.41	0.15	0.53	-0.87	0.17	-0.19	-0.8	0.07	-0.3	0.53	-0.32	0.16	0.03		-0.91	0.39	-0.12	0.52	-0.88	0.29
Cash	0.39	0.46	0.25	0.59	-0.2	0.63	0.19	0.11	-0.16	0.81	0.14	0.42	0.98	0.23	0.63	-0.24	0.63	0.01	-0.39	-0.91		-0.1	0.09	-0.18	0.99	-0.6
Non Current Assets Total	0.76	0.63	0.03	0.67	-0.92	0.11	-0.37	0.84	0.75	-0.47	0.89	0.67	0.07	0.88	0.7	0.91	0.71	0.57	-0.86	0.39	-0.1		-0.61	0.51	-0.03	-0.72
Non Currrent Assets Other	-0.68	-0.73	0.02	-0.31	0.44	-0.61	-0.17	-0.71	-0.06	0.22	-0.35	-0.37	0.01	-0.46	-0.38	-0.27	-0.4	-0.87	0.46	-0.12	0.09	-0.61		0.31	0.1	0.46
Long Term Debt	0.14	-0.03	0.06	0.38	-0.6	-0.64	-0.66	0.26	0.89	-0.41	0.58	0.26	-0.03	0.45	0.34	0.73	0.3	-0.07	-0.48	0.52	-0.18	0.51	0.31		-0.1	-0.28
Cash And Short Term Investments	0.42	0.47	0.25	0.64	-0.27	0.6	0.14	0.15	-0.09	0.77	0.23	0.48	0.98	0.3	0.68	-0.14	0.68	-0.01	-0.46	-0.88	0.99	-0.03	0.1	-0.1		-0.65
Non Current Liabilities Total	-0.89	-0.86	-0.2	-0.94	0.88	-0.53	0.16	-0.77	-0.5	-0.19	-0.78	-0.8	-0.74	-0.84	-1.0	-0.53	-1.0	-0.55	0.96	0.29	-0.6	-0.72	0.46	-0.28	-0.65

Click cells to compare fundamentals

GeneDx Holdings Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeneDx Stock Based Compensation vs Depreciation Analysis

Stock Based Compensation vs Depreciation

Stock Based Compensation vs Depreciation Correlation Analysis

Correlation Coefficient

Stock Based Compensation

Depreciation

GeneDx Holdings fundamental ratios Correlations

GeneDx Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for GeneDx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Property Plant Equipment	+ 0.98	Other Current Assets
Cash	+ 0.98	Total Current Assets
Cash And Short Term Investments	+ 0.98	Total Current Assets
Total Current Liabilities	+ 0.97	Other Current Liab

Non Current Liabilities Total	- 1.0	Total Stockholder Equity
Non Current Liabilities Total	- 1.0	Total Assets
Current Deferred Revenue	- 0.96	Total Stockholder Equity
Current Deferred Revenue	- 0.96	Total Assets
Property Plant Equipment	- 0.94	Retained Earnings
Other Current Assets	- 0.94	Retained Earnings